Q-linea AB (publ) (STO:QLINEA)
Sweden
· Delayed Price · Currency is SEK 0.0370
-0.0010 (-2.63%)
Apr 29, 2025, 9:52 AM CET
Q-linea AB Company Description
Q-linea AB (publ) engages in the development of instruments and consumables for infection diagnostics in the United Kingdom.
The company offers ASTar, an antibiotic susceptibility testing system used for positive blood cultures; and in vitro diagnostics systems for infectious diseases.
It serves healthcare providers. The company was incorporated in 2007 and is headquartered in Uppsala, Sweden.
Q-linea AB (publ)
| Country | Sweden |
| Founded | 2007 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 94 |
| CEO | Stuart Gander |
Contact Details
Address: Dag HammarskjOelds vAeg 52 A Uppsala, 752 37 Sweden | |
| Phone | 46 1 84 44 36 10 |
| Website | qlinea.com |
Stock Details
| Ticker Symbol | QLINEA |
| Exchange | Nasdaq Stockholm |
| Fiscal Year | January - December |
| Reporting Currency | SEK |
| ISIN Number | SE0011527845 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Stuart Gander | Chief Executive Officer |
| Christer Samuelsson | Chief Financial Officer and IR |
| Henrik Jacobson | Chief Operating Officer |
| Ulrika Stolpe | HR Manager |
| Tiziana Di Martino | Chief Medical Officer |
| Thomas Fritz | Chief Commercial Officer |
| Anders Ljunggren | Managing Director |
| Victoria Lerneryd | Manager of QA/RA |